ArticleScientific reports2026
Electrolyte abnormalities and clinical outcomes in heart failure patients: a retrospective cohort study using MIMIC-IV database.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electrolyte abnormalities commonly complicate heart failure management, yet their prognostic significance and optimal monitoring strategies remain incompletely characterized. We examined the prevalence, temporal patterns, and clinical outcomes associated with electrolyte abnormalities in hospitalized heart failure patients. Retrospective cohort study of 30,678 heart failure patients (80,408 admissions) from the MIMIC-IV database (2008-2022). Clinically significant electrolyte abnormalities (CSEA) were defined as patients whose potassium remained consistently < 3.5 or > 5.0 mEq/L, or whose sodium remained consistently < 135 or > 145 mEq/L throughout all measurements during hospitalization. Primary outcomes were 30-day all-cause readmission and mortality. We developed a clinical risk score incorporating electrolyte abnormalities and examined temporal electrolyte patterns. CSEA occurred in 950 patients (3.1%) in the full cohort, of whom 713 (2.3%) survived to discharge and constituted the primary analysis cohort for post-discharge outcomes. Patients with abnormalities had paradoxically lower 30-day readmission (3.9% vs 15.3%; adjusted HR 0.29, 95% CI 0.21-0.40) but substantially higher mortality (15.4% vs 7.0%; adjusted HR 1.93, 95% CI 1.57-2.38), reflecting competing mortality risk. Individual electrolyte abnormalities were independently associated with mortality: hypokalemia HR 1.45 (1.28-1.65), hyperkalemia HR 1.67 (1.48-1.89), hyponatremia HR 1.34 (1.19-1.51). Temporal analysis revealed biphasic patterns-initial correction followed by recurrence-identified the highest-risk subset (composite event rates 27.6% for potassium, 28.5% for sodium). A five-variable risk score (electrolyte abnormality, age ≥ 75, chronic kidney disease, multiple admissions, coronary artery disease) achieved C-statistic 0.593. CSEA are independently associated with mortality in heart failure patients despite paradoxically lower readmission rates due to competing risks. Biphasic electrolyte patterns identify particularly high-risk patients. Simple risk stratification using routinely collected electrolyte data may enhance post-discharge risk prediction and inform targeted monitoring strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.